Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Fortress Biotech (FBIO) over the last 4 years, with Dec 2024 value amounting to -$2.69.

  • Fortress Biotech's EPS (Weighted Average and Diluted) rose 114.47% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year increase of 94.12%. This contributed to the annual value of -$2.69 for FY2024, which is 68.24% up from last year.
  • Fortress Biotech's EPS (Weighted Average and Diluted) amounted to -$2.69 in FY2024, which was up 68.24% from -$8.47 recorded in FY2023.
  • Fortress Biotech's 5-year EPS (Weighted Average and Diluted) high stood at -$0.79 for FY2021, and its period low was -$15.97 during FY2022.
  • For the 3-year period, Fortress Biotech's EPS (Weighted Average and Diluted) averaged around -$9.04, with its median value being -$8.47 (2023).
  • In the last 5 years, Fortress Biotech's EPS (Weighted Average and Diluted) tumbled by 1,921.52% in 2022 and then surged by 68.24% in 2024.
  • Yearly analysis of 4 years shows Fortress Biotech's EPS (Weighted Average and Diluted) stood at -$0.79 in 2021, then slumped by 1,921.52% to -$15.97 in 2022, then skyrocketed by 46.96% to -$8.47 in 2023, then skyrocketed by 68.24% to -$2.69 in 2024.